These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18227521)

  • 1. Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913-1921, 2007.
    Chalew S; Hempe J; McCarter R
    Diabetes; 2008 Feb; 57(2):e4; author reply e5. PubMed ID: 18227521
    [No Abstract]   [Full Text] [Related]  

  • 2. The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial.
    Lachin JM; Genuth S; Nathan DM; Rutledge BN
    Diabetes; 2007 Jul; 56(7):1913-21. PubMed ID: 17360979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 4. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.
    Fleischer J; Cichosz SL; Hansen TK
    Diabetes Care; 2017 Nov; 40(11):e164. PubMed ID: 29061593
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777-783.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Nov; 40(11):e165-e166. PubMed ID: 29061594
    [No Abstract]   [Full Text] [Related]  

  • 7. Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.
    El-Asrar MA; Andrawes NG; Ismail EA; Salem SM
    Vasc Med; 2015 Dec; 20(6):509-17. PubMed ID: 26091968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevelance of microvascular complications in adolescents with Type 1 diabetes.
    Lunt H; Moore MP; Kendall D; Willis JA; Anderson P
    Diabet Med; 2003 May; 20(5):421-2. PubMed ID: 12752496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Near-norm blood sugar regulation in diabetes. Myocardial infarct rate halved].
    MMW Fortschr Med; 2005 Sep; 147(35-36):4-5. PubMed ID: 16180560
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabetologia; 2008 Feb; 51(2):365-71. PubMed ID: 18040661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic complications. The importance of glucose control.
    Skyler JS
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):243-54. PubMed ID: 8799699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control and CAD risk: a heretical thought.
    Orchard TJ
    Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
    [No Abstract]   [Full Text] [Related]  

  • 14. Reexamining metrics for glucose control.
    Rubinow KB; Hirsch IB
    JAMA; 2011 Mar; 305(11):1132-3. PubMed ID: 21406652
    [No Abstract]   [Full Text] [Related]  

  • 15. Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications.
    Hirsch IB; Brownlee M
    JAMA; 2010 Jun; 303(22):2291-2. PubMed ID: 20530784
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Ceriello A; Prattichizzo F
    Diabetes Care; 2023 Jan; 46(1):e12. PubMed ID: 36548708
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448.
    Lachin JM; Bebu I; Gao X; Nathan DM; Zinman B
    Diabetes Care; 2023 Jan; 46(1):e13. PubMed ID: 36548707
    [No Abstract]   [Full Text] [Related]  

  • 18. Metrics for monitoring glycemic control.
    Chalew S; Hempe J; McCarter R
    JAMA; 2011 Jun; 305(24):2522; author reply 2522-3. PubMed ID: 21693738
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular complications and risk factors in patients with type 2 diabetes.
    Del Cañizo Gómez FJ; Fernández Pérez C; Moreno Ruiz I; de Gorospe Pérez-Jáuregui C; Silveira Rodríguez B; González Losada T; Segura Galindo A
    Endocrinol Nutr; 2011 Apr; 58(4):163-8. PubMed ID: 21411384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.